Free Trial

Medifast (MED) Competitors

Medifast logo
$14.03 -0.23 (-1.61%)
Closing price 03:58 PM Eastern
Extended Trading
$14.02 -0.01 (-0.11%)
As of 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MED vs. LW, NOMD, NUS, USNA, NATR, VERU, EL, IPAR, PBH, and HLF

Should you be buying Medifast stock or one of its competitors? The main competitors of Medifast include Lamb Weston (LW), Nomad Foods (NOMD), Nu Skin Enterprises (NUS), USANA Health Sciences (USNA), Nature's Sunshine Products (NATR), Veru (VERU), Estee Lauder Companies (EL), Interparfums (IPAR), Prestige Consumer Healthcare (PBH), and Herbalife (HLF).

Medifast vs. Its Competitors

Lamb Weston (NYSE:LW) and Medifast (NYSE:MED) are both consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Lamb Weston has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500. Comparatively, Medifast has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500.

In the previous week, Lamb Weston had 15 more articles in the media than Medifast. MarketBeat recorded 20 mentions for Lamb Weston and 5 mentions for Medifast. Lamb Weston's average media sentiment score of 1.28 beat Medifast's score of 0.00 indicating that Lamb Weston is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Lamb Weston
16 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Medifast
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Lamb Weston has a net margin of 5.54% compared to Medifast's net margin of 0.76%. Lamb Weston's return on equity of 27.99% beat Medifast's return on equity.

Company Net Margins Return on Equity Return on Assets
Lamb Weston5.54% 27.99% 6.43%
Medifast 0.76%2.00%1.50%

89.6% of Lamb Weston shares are owned by institutional investors. Comparatively, 95.5% of Medifast shares are owned by institutional investors. 0.3% of Lamb Weston shares are owned by insiders. Comparatively, 2.9% of Medifast shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Lamb Weston has higher revenue and earnings than Medifast. Lamb Weston is trading at a lower price-to-earnings ratio than Medifast, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lamb Weston$6.45B1.22$357.20M$2.5122.42
Medifast$602.46M0.26$2.09M$0.3243.84

Lamb Weston currently has a consensus target price of $65.30, suggesting a potential upside of 16.04%. Medifast has a consensus target price of $16.50, suggesting a potential upside of 17.61%. Given Medifast's higher probable upside, analysts clearly believe Medifast is more favorable than Lamb Weston.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lamb Weston
0 Sell rating(s)
7 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.30
Medifast
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Lamb Weston beats Medifast on 11 of the 16 factors compared between the two stocks.

Get Medifast News Delivered to You Automatically

Sign up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MED vs. The Competition

MetricMedifastFOOD IndustryStaples SectorNYSE Exchange
Market Cap$154.19M$8.29B$16.06B$21.29B
Dividend YieldN/A3.41%3.03%3.53%
P/E Ratio43.8522.4018.2829.36
Price / Sales0.261.7647.6974.71
Price / Cash4.7612.8114.7923.64
Price / Book0.713.435.835.38
Net Income$2.09M$401.69M$677.55M$996.59M
7 Day Performance3.25%1.05%1.23%3.12%
1 Month Performance-3.77%-1.90%-1.69%2.97%
1 Year Performance-25.49%-5.56%3.96%12.83%

Medifast Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MED
Medifast
3.2356 of 5 stars
$14.03
-1.6%
$16.50
+17.6%
-25.7%$154.19M$602.46M43.85870Analyst Revision
LW
Lamb Weston
4.531 of 5 stars
$55.96
-1.8%
$65.30
+16.7%
-8.9%$7.94B$6.45B22.3010,100Positive News
NOMD
Nomad Foods
4.5459 of 5 stars
$15.75
+1.0%
$20.33
+29.1%
-15.9%$2.39B$3.35B10.797,788
NUS
Nu Skin Enterprises
4.2447 of 5 stars
$12.02
-0.9%
$6.88
-42.8%
+31.8%$600.41M$1.73B5.983,100
USNA
USANA Health Sciences
4.2195 of 5 stars
$31.87
-1.2%
$36.00
+13.0%
-20.9%$589.08M$854.50M17.701,700News Coverage
Positive News
NATR
Nature's Sunshine Products
3.3252 of 5 stars
$16.59
+1.2%
$19.67
+18.5%
+24.8%$289.22M$454.36M22.42850Positive News
VERU
Veru
2.5915 of 5 stars
$3.49
-3.1%
$33.33
+855.1%
-60.8%$52.77M$16.89M-1.59230Positive News
EL
Estee Lauder Companies
4.1047 of 5 stars
$88.72
-2.8%
$87.80
-1.0%
-0.1%$32.82B$14.33B-28.2557,000Insider Trade
Analyst Revision
IPAR
Interparfums
4.2769 of 5 stars
$115.00
-1.0%
$162.00
+40.9%
-6.5%$3.73B$1.45B23.05530News Coverage
Positive News
PBH
Prestige Consumer Healthcare
4.6906 of 5 stars
$65.69
-1.5%
$93.33
+42.1%
-7.7%$3.28B$1.14B15.42540
HLF
Herbalife
4.5674 of 5 stars
$9.47
-2.8%
$11.50
+21.5%
+12.9%$1.00B$4.99B2.998,600Positive News

Related Companies and Tools


This page (NYSE:MED) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners